Literature DB >> 15370020

A brief motivational intervention for substance misuse in recent-onset psychosis.

David J Kavanagh1, Ross Young, Angela White, John B Saunders, Jeff Wallis, Natalie Shockley, Linda Jenner, Anne Clair.   

Abstract

Substance misuse is common in early psychosis, and impacts negatively on outcomes. Little is known about effective interventions for this population. We report a pilot study of brief intervention for substance misuse in early psychosis (Start Over and Survive: SOS), comparing it with Standard Care (SC). Twenty-five in-patients aged 18-35 years with early psychosis and current misuse of non-opioid drugs were allocated randomly to conditions. Substance use and related problems were assessed at baseline, 6 weeks and 3, 6 and 12 months. Final assessments were blind to condition. All 13 SOS participants who proceeded to motivational interviewing reported less substance use at 6 months, compared with 58% (7/12) in SC alone. Effects were well maintained to 12 months. However, more SOS participants lived with a relative or partner, and this also was associated with better outcomes. Engagement remained challenging: 39% (16/41) declined participation and 38% (5/13) in SOS only received rapport building. Further research will increase sample size, and address both engagement and potential confounds.

Entities:  

Mesh:

Year:  2004        PMID: 15370020     DOI: 10.1080/09595230410001704127

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  22 in total

Review 1.  Prevalence and impact of substance use among emerging adults with serious mental health conditions.

Authors:  Ashli J Sheidow; Michael McCart; Kristyn Zajac; Maryann Davis
Journal:  Psychiatr Rehabil J       Date:  2012

2.  A randomized controlled trial of family intervention for co-occurring substance use and severe psychiatric disorders.

Authors:  Kim T Mueser; Shirley M Glynn; Corrine Cather; Haiyi Xie; Roberto Zarate; Lindy Fox Smith; Robin E Clark; Jennifer D Gottlieb; Rosemarie Wolfe; James Feldman
Journal:  Schizophr Bull       Date:  2012-01-26       Impact factor: 9.306

Review 3.  Treatment of substance use disorders in schizophrenia: a unifying neurobiological mechanism?

Authors:  Robert M Roth; Mary F Brunette; Alan I Green
Journal:  Curr Psychiatry Rep       Date:  2005-08       Impact factor: 5.285

Review 4.  Early intervention for psychosis.

Authors:  Max Marshall; John Rathbone
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15

Review 5.  Antipsychotic medication for early episode schizophrenia.

Authors:  John Bola; Dennis Kao; Haluk Soydan
Journal:  Cochrane Database Syst Rev       Date:  2011-06-15

6.  A pilot investigation of the Graduated Recovery Intervention Program (GRIP) for first episode psychosis.

Authors:  David L Penn; Sarah R Uzenoff; Diana Perkins; Kim T Mueser; Robert Hamer; Evan Waldheter; Sylvia Saade; Liz Cook
Journal:  Schizophr Res       Date:  2011-02       Impact factor: 4.939

7.  Secondary prevention of hazardous alcohol consumption in psychiatric out-patients: a randomised controlled study.

Authors:  Sophia Eberhard; Göran Nordström; Peter Höglund; Agneta Ojehagen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2009-03-18       Impact factor: 4.328

Review 8.  The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements.

Authors:  Lisa B Dixon; Faith Dickerson; Alan S Bellack; Melanie Bennett; Dwight Dickinson; Richard W Goldberg; Anthony Lehman; Wendy N Tenhula; Christine Calmes; Rebecca M Pasillas; Jason Peer; Julie Kreyenbuhl
Journal:  Schizophr Bull       Date:  2009-12-02       Impact factor: 9.306

9.  Predicting post-treatment-initiation alcohol use among patients with severe mental illness and alcohol use disorders.

Authors:  Clara M Bradizza; Stephen A Maisto; Paula C Vincent; Paul R Stasiewicz; Gerard J Connors; Nicole D Mercer
Journal:  J Consult Clin Psychol       Date:  2009-12

10.  Psychosocial Interventions in Reducing Cannabis Use in Early Phase Psychosis: A Canadian Survey of Treatments Offered.

Authors:  Cristina Aydin; Philip G Tibbo; Zenovia Ursuliak
Journal:  Can J Psychiatry       Date:  2016-03-16       Impact factor: 4.356

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.